Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inspire Medical Systems Inc (INSP)

Inspire Medical Systems Inc (INSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,816,397
  • Shares Outstanding, K 29,056
  • Annual Sales, $ 802,800 K
  • Annual Income, $ 53,510 K
  • EBIT $ 37 M
  • EBITDA $ 34 M
  • 60-Month Beta 0.72
  • Price/Sales 3.30
  • Price/Cash Flow 57.58
  • Price/Book 4.29

Options Overview Details

View History
  • Implied Volatility 70.52% (-4.93%)
  • Historical Volatility 79.45%
  • IV Percentile 82%
  • IV Rank 62.70%
  • IV High 87.31% on 11/03/25
  • IV Low 42.30% on 02/11/25
  • Expected Move (DTE 3) 3.54 (3.85%)
  • Put/Call Vol Ratio 0.20
  • Today's Volume 912
  • Volume Avg (30-Day) 1,084
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 15,276
  • Open Int (30-Day) 11,352
  • Expected Range 88.30 to 95.38

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.69
  • Number of Estimates 6
  • High Estimate 0.77
  • Low Estimate 0.61
  • Prior Year 1.15
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
89.94 +1.80%
on 12/18/25
134.66 -32.01%
on 12/15/25
-39.12 (-29.94%)
since 12/12/25
3-Month
71.45 +28.15%
on 11/03/25
147.03 -37.73%
on 12/10/25
+13.88 (+17.87%)
since 10/13/25
52-Week
70.77 +29.38%
on 10/01/25
203.12 -54.92%
on 02/05/25
-83.87 (-47.81%)
since 01/13/25

Most Recent Stories

More News
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance

MINNEAPOLIS, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization...

INSP : 92.67 (-4.39%)
1 Growth Stock Set to Flourishand 2 That Underwhelm

1 Growth Stock Set to Flourishand 2 That Underwhelm

INSP : 92.67 (-4.39%)
ATLC : 59.61 (-0.18%)
NX : 17.91 (+1.19%)
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading...

INSP : 92.67 (-4.39%)
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss...

INSP : 92.67 (-4.39%)
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Find Risky

1 of Wall Street’s Favorite Stock to Target This Week and 2 We Find Risky

INSP : 92.67 (-4.39%)
ENR : 21.20 (+1.58%)
MATX : 132.01 (-0.18%)
2-DAY DEADLINE ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut

Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline

INSP : 92.67 (-4.39%)
Deadline Soon: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming January 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed...

INSP : 92.67 (-4.39%)
Investors in Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP

NEW YORK , Jan. 2, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc." or the "Company") (NYSE: INSP) of a class action...

INSP : 92.67 (-4.39%)
5-DAY DEADLINE ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut

Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline

INSP : 92.67 (-4.39%)
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options

INSP : 92.67 (-4.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea....

See More

Key Turning Points

3rd Resistance Point 105.69
2nd Resistance Point 102.10
1st Resistance Point 99.51
Last Price 92.67
1st Support Level 93.33
2nd Support Level 89.74
3rd Support Level 87.15

See More

52-Week High 203.12
Fibonacci 61.8% 152.56
Fibonacci 50% 136.94
Fibonacci 38.2% 121.33
Last Price 92.67
52-Week Low 70.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar